-
425 Madison Ave, Fl 14
New York, NY, 10017
(212)644 9100
Make the decision to pursue this treatment and embark on a path towards relief by consulting with our healthcare provider about our prescription-only solution.
Spravato® (esketamine) provides a proven, rapid, and superior reduction in depressive symptoms, with noticeable improvement seen within 24 hours. Choose us to effectively restore your well-being in less time on your journey to recovery.
SERVICING MIDTOWN MANHATTAN AND SURROUNDING AREA
Spravato treatment might be fully covered by your insurance, please contact us to verify your benefits.
Ready for a new approach?
We offer two ways to get started:
Schedule your consultation.
Our care counselor will reach out to help you schedule your consultation.
Get a referral from your provider.
Discuss our services with your provider and have them reach out.
Get started today
ABOUT US
We meet you wherever you are on your mental health journey, providing personalized and holistic approaches to address resistant depression. Our continuum of care begins with a consultation with medical professionals to discuss and evaluate.
Follow by Spravato® sessions, a medical assistant is available to assist throughout the treatment. Additionally, the option to speak with a mental health therapist during these sessions is also available.
OUR MISSION
Create a new model of mental healthcare that is outcomes-focused, comprehensive, and accessible for all. Unlike most mental health providers, we accept out-of-network insurance plans insurance, paving the way for more people to get the treatment they deserve.
The results differentiate us.
Why choose Madison KetaHealth NYC
Innovation-driven: Madison KetaHealth NYC combines innovations in therapeutics, insurance policy coverage, and data science to optimize patient experiences for outcomes, access, and affordability.
Collaborative: Our doctors, therapist and medical assistants believe in working as a team to achieve optimal results.
Accessible and affordable: We accept most major insurance policies and promise to handle all communications with your plan.
Doctors answer patients’ top 9 questions about SPRAVATO®.
Be sure to watch the entire video to get the full SPRAVATO® story, including safety information.
Briana Bennett
Medical Assistant
Briana coordinates
treatment and provides
support and education to
all of our Spravato® patients.
Ruth Johnson
Functional Medicine Specialist
Dr. Ruth Johnson is the Medical Director at Madison KetaHealth NYC. She specializes in functional medicine and is dedicated to providing natural supportive therapies for mental health.
Fairuz Abdalla
Medical Assistant
Fairuz provides assistance in scheduling appointments and coordinating care for all of our Madison KetaHealth patients.
At Madison KetaHealth NYC, we offer Spravato® treatment to patients who qualify under their insurance plan and in accordance with FDA’s safety requirements.
Meet with a medical director to determine your treatment protocol. During this 2-hours session, you and a Madison KetaHealth NYC clinician will discuss your history, current symptoms, and treatment options.
Appointments are typically twice weekly for the first month, and once weekly for the second month. Treatment is under the supervision of your prescriber — then you’ll sit back, relax, and allow the effects to unfold. Sessions are two hours in length.
SPRAVATO® helped Nicole’s treatment-resistant depression. Now, she’s resuming her education and sharing her story.
Allison’s son tried many oral antidepressants without relief. Now, because of SPRAVATO®, Allison’s son is starting to feel like himself again.
Spravato® is the brand name for esketamine (a version of ketamine) nasal spray, which is prescribed as a fast-acting treatment for treatment-resistant depression.
Although the exact mechanism of action is not yet known, Spravato® is thought to create new connections in the brain by targeting the glutamate system, which is responsible for facilitating communication between nerve cells. This is referred to as neuroplasticity — the ability of the brain to change and adapt. By increasing neuroplasticity, Spravato® appears to help behavioral and cognitive changes occur more rapidly in patients with treatment-resistant depression.
There are several differences between Spravato® and ketamine.
On a basic level, Spravato® is the brand name for the compound esketamine, which is derived from isolating one component of ketamine. Ketamine has a longer history, as well, though it’s not FDA-approved to treat depression. That brings us to a key difference in terms of access and cost: Spravato® is covered by insurance, while ketamine is not.
The most common side effects of Spravato®, which can occur both during and after treatment, include: feelings of dissociation (disconnectedness from your body/thoughts/feelings); lack of energy or fatigue; dizziness; increased blood pressure; feeling drunk or excited; nausea or vomiting. Unlike the side effects associated with oral antidepressants, which are persistent and systemic, side effects from Spravato® typically go away within hours of treatment. To avoid nausea and vomiting, it’s recommended that you avoid eating two hours before your treatment.
After your initial consultation, Spravato® sessions are typically scheduled twice a week for the first month. In the second month, sessions are reduced to once a week. After this two month period, you and your provider can discuss whether or not to continue Spravato® treatment (and at what frequency) based on your progress. Each session lasts about minimum 2 hours required for this treatment.
Available at Heading, this cutting-edge therapy works quickly to alleviate symptoms when other treatments haven’t been effective. With its fast-acting relief, patients can find renewed hope and a path towards a brighter, healthier future. Unlock the potential for healing with Spravato® and take the first step towards overcoming depression today.
If you need immediate medical attention dial 911.
If you are in mental health crisis help is available via the crisis hotline, dial 988.
